Canandaigua National Corp’s Bristol-Myers Squibb BMY Stock Holding History

Canandaigua National Corp’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.47M	Buy	+24,182	New	+$1.41M	0.13%	144
2022 Q4	$4.71M	Sell	65,452 -810	-1%	-$61.1K	0.8%	33
2022 Q3	$4.71M	Sell	66,262 -3,297	-5%	-$239K	0.84%	30
2022 Q2	$5.36M	Sell	69,559 -3,073	-4%	-$234K	0.95%	27
2022 Q1	$5.3M	Sell	72,632 -14,252	-16%	-$957K	0.81%	37
2021 Q4	$5.42M	Sell	86,884 -516	-0.6%	-$30.3K	0.8%	40
2021 Q3	$5.17M	Buy	87,400 +4,672	+6%	+$308K	0.84%	38
2021 Q2	$5.53M	Sell	82,728 -328	-0.4%	-$21.4K	0.9%	34
2021 Q1	$5.24M	Sell	83,056 -3,676	-4%	-$229K	0.89%	36
2020 Q4	$5.38M	Buy	86,732 +922	+1%	+$56.7K	0.95%	31
2020 Q3	$5.17M	Buy	85,810 +2,579	+3%	+$155K	0.91%	31
2020 Q2	$4.89M	Buy	+83,231	New	+$4.98M	0.9%	34

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Canandaigua National Corp's BMY Position: Q1 2026 in Review

Canandaigua National Corp opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 24,182 shares worth $1.47M. The stake represents 0.13% of the portfolio and ranks #144 among its holdings. This is a return to the name: Canandaigua National Corp previously reported a position in BMY as recently as Q4 2022.

Canandaigua National Corp first reported a position in BMY in Q2 2020 and has held it in 12 quarters since. The position peaked at $5.53M in Q2 2021. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Canandaigua National Corp held 24,182 shares of Bristol-Myers Squibb worth $1.47M as of Q1 2026.
Bristol-Myers Squibb was a new Canandaigua National Corp position in Q1 2026.
Bristol-Myers Squibb made up 0.13% of Canandaigua National Corp's portfolio in Q1 2026, its #144 holding.
Canandaigua National Corp first reported a position in Bristol-Myers Squibb in Q2 2020 and has held it in 12 quarters since.
Canandaigua National Corp's Bristol-Myers Squibb position peaked at $5.53M in Q2 2021.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Canandaigua National Corp's 13F filing for Q1 2026, filed 8 Apr 2026.